FindTrial
Sign In

Conventional radiation therapy

RADIATION3 trials

Sponsors

Janssen Research & Development, LLC, Changhai Hospital, University Health Network, Toronto

Conditions

Histopathologically or Cytologically Confirmed Solid Tumor Who Require Palliation Radiation Therapy to a Lesion ≥5cmLocalized Prostate CancerUrinary Bladder Neoplasms

Phase 3

A Study of TAR-200 in Combination With Cetrelimab Versus Concurrent Chemoradiotherapy in Participants With Muscle-invasive Bladder Cancer (MIBC) of the Bladder
Active, not recruitingNCT04658862
Janssen Research & Development, LLCUrinary Bladder Neoplasms
Start: 2020-12-07End: 2028-12-31Updated: 2026-03-19
Lattice Radiation Therapy Versus Conventional Radiation Therapy for the Palliation of Large Tumors
RecruitingNCT07444775
University Health Network, TorontoHistopathologically or Cytologically Confirmed Solid Tumor Who Require Palliation Radiation Therapy to a Lesion ≥5cm
Start: 2025-11-18End: 2028-01-01Target: 148Updated: 2026-03-03

Unknown Phase

Hypofractionated Post-prostatectomy Radiotherapy (HYPORT)for Localized Prostate Cancer
RecruitingNCT06325995
Changhai HospitalLocalized Prostate Cancer
Start: 2024-02-01End: 2031-02-01Target: 428Updated: 2024-08-26

Related Papers

The Safety, Tolerability, and Preliminary Efficacy of a Gemcitabine-releasing Intravesical System (TAR-200) in American Urological Association-defined Intermediate-risk Non-muscle-invasive Bladder Cancer Patients: A Phase 1b Study.
2024-02-1615 citations
MP13-17 SUNRISE-2: A PHASE 3, MULTICENTER, RANDOMIZED STUDY EVALUATING THE EFFICACY OF TAR-200 IN COMBINATION WITH CETRELIMAB VERSUS CONCURRENT CHEMORADIOTHERAPY IN PARTICIPANTS WITH MUSCLE-INVASIVE UROTHELIAL CARCINOMA OF THE BLADDER
The Journal of Urology2021-08-043 citations
A phase 3, multicenter, randomized study evaluating the efficacy of TAR-200 in combination with cetrelimab versus concurrent chemoradiotherapy in participants with muscle-invasive urothelial carcinoma of the bladder.
Journal of Clinical Oncology2021-05-205 citations